Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins

Journal of Biomedical Materials Research

Volumn 50, Issue 3, 2000, Pages 388-396

  Eliaz, Rom E ^a,b   Kost, Joseph ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biodegradable polymers; In situ; Injectable implant; Peptide protein delivery system; TNF soluble receptors

Indexed keywords

AMINO ACIDS; BIOCOMPATIBILITY; BIODEGRADATION; COPOLYMERS; MOLECULAR WEIGHT; POLYESTERS; PROTEINS;

POLYGLYCOLIDE; POLYLACTIDE;

IMPLANTS (SURGICAL);

COPOLYMER; POLYGLACTIN;

ARTICLE; BIODEGRADABLE IMPLANT; BIODEGRADATION; CHEMICAL COMPOSITION; CONTROLLED RELEASE FORMULATION; DEVICE; IMPLANTATION; KINETICS; MOLECULAR WEIGHT; PRECIPITATION; PROTEIN SECRETION; VISCOSITY;

ANIMALS; BIOCOMPATIBLE MATERIALS; CHO CELLS; CRICETINAE; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; LACTIC ACID; POLYGLYCOLIC ACID; POLYMERS; PROTEINS;

EID: 0034110737     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(20000605)50:3<388::AID-JBM13>3.0.CO;2-F     Document Type: Article

References (22)

1. Lewis DH. Controlled release of bioactive agents from lactide/ glycolide polymers. In: Chasin M, Langer R, editors. Biodegradable polymers as drug delivery systems. New York: Marcel Dekker, Inc.; 1990. p 1-42.
2. Jail R, Nixon R. Biodegradable poly (lactic acid) and poly (lactide-co-glycolide) microencapsules: Problem associated with preparative techniques and release properties. J Microencapsulation 1990;7:297-325.
3. Dunn R, Hardee G, Polson A, Bennet A, Martin S, Wardley R, Moseley W, Krinick N, Foster T, Frank K, Cox S. In-situ forming biodegradable implants for controlled release veterinary applications. Proc Intern Symp Control Rel Bioact Mater 1995; 22:91-92.
4. Dunn RL, Yewey GL, Fujita SM, Josephs KR, Whitman SL, Southard GL, Dernell WS, Straw RC, Withrow SJ, Powers BE. Sustained release of cisplatin in dogs from an injectable implant delivery system. J Bioact Compat Polym 1996;11:286-300.
5. Tipton AJ, Fujita SM, Frank KR, Dunn RL. A biodegradable injectable delivery system for nonsteroidal anti-inflammatory drugs. Pharm Res 1991;8:S196.
6. IM injectable implant system. Proc Intern Symp Control Rel Bioact Mater 1993; 20:458-459.
7. Tauboll E, Lindstro S, Klem W, Gjerstad L. A new injectable carbamazepine solution - Antiepileptic effects and pharmaceutical properties. Epilepsy Res 1990;7:59-64.
8. Handbook of pharmaceutical excipients. American Pharmaceutical Association and Pharmaceutical Society of Great Britain; 1994. p 127.
9. Aderka D, Englemann H, Hornik V, Skornick Y, Levo Y, Wallach D, Kushtai G. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res 1991; 51:5602-5607.
10. Barrera DA, Zylstra E, Lansbury PT, Langer R. Copolymerization and degradation of poly(lactic acid co-lysine). Macromolecules 1995;28:425-432.
11. Park TG. Degradation of poly(lactic-co-glycolic acid) microspheres: Effect of copolymer composition. Biomaterials 1995; 16:1123-1130.
12. Park TG. Degradation of poly(D,L-lactic acid) microspheres: Effect of molecular weight. J Controlled Release 1994;30:161-173.
13. Jamshidi K, Hyon SH, Ikada Y. Thermal characterization of polylactides. Polymer 1988;29:2229-2234.
14. Vert M, Li SM, Garreau H. Attempts to map the structure and degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. J Biomater Sci, Polym Edn 1994; 6:639-649.
15. Vert M, Li S, Gerreau H. More about the degradation of LA/ GA-derived matrices in aqueous media. J Controlled Release 1991;16:15-26.
16. Eliaz R, Wallach D, Kost J. Long-term protection against the effects of tumor necrosis factor by controlled delivery of the soluble p55 TNF receptor. Cytokine 1996;8:482-487.
17. Cohen S, Yoshida T, Lucarelli M, Hwang LH, Langer R. Controlled delivery system for proteins based on poly (lactic/ glycolic acid) microspheres. Pharm Res 1991;8:713-720.
18. Cohen S, Chen L, Apte RN. Controlled release peptides and proteins from biodegradable polyester microspheres: An approach for treating infections and malignancies. Reactive Polym 1995;25:177-187.
19. Chen L, Apte RN, Cohen S. Characterization of PLGA microspheres for the controlled delivery of IL-1α for tumor immunotherapy. J Controlled Release 1997;43:261-272.
20. Kozinski AA, Lightfoot EN. Protein ultrafiltration: A general example of boundary layer filtration. Am Inst Chem Eng J 1972;18:1030-1040.
21. Gilding DK, Reed AM. Biodegradable polymers for use in surgery - poly (glycolic)/poly(lactic acid) homo- and copolymers. I. In vitro degradation. Polymer 1979;20:1459-1464.
22. Reed AM, Gilding DK. Biodegradable polymers for use in surgery - poly (glycolic)/poly(lactic acid) homo- and copolymers. II. In vivo degradation. Polymer 1981;22:494-498.